IBIO vs NVR · rev $100.0K vs P/E 15, rev $4.21B
iBio, Inc. Common Stock (IBIO) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
IBIO currently screens at market cap $13.4M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the IBIO and NVR stock pages for the full models.
Not investment advice.